EP.01.19 Characteristics of Lung Cancer in Never- and Light-Smokers: A Retrospective Study From Greece
G. Gomatou(University General Hospital Attikon), Panagiota Economopoulou(National and Kapodistrian University of Athens), Anastasios Pantazopoulos(University General Hospital Attikon), M. Roumpoutsou(University General Hospital Attikon), Areti Kalfoutzou(Hellenic Air Force), Μaria Anastasiou(National and Kapodistrian University of Athens), N. Gavrielatou(University General Hospital Attikon), Anastasios Kyriazoglou(Alexandra Hospital), Anna Boulouta(National and Kapodistrian University of Athens), Amanda Psyrri(National and Kapodistrian University of Athens), Ioannis Kotsantis(National and Kapodistrian University of Athens), Lydia Evangelia Gkaralea(Hospital Agioi Anargyroi), Çağatay Çağlar(University General Hospital Attikon), M. Moutafi(University General Hospital Attikon), Theodora Frantzi(University General Hospital Attikon), Andreas Sofis(University General Hospital Attikon), Evangelos Zazas(National and Kapodistrian University of Athens)
Cited by 0
Related Papers
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
|The Lancet Oncology|2021|618
Head and neck squamous cell cancer and the human papillomavirus: Summary of a National Cancer Institute State of the Science Meeting, November 9–10, 2008, Washington, D.C.
|Head & Neck|2009|265
Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III study
|Annals of Oncology|2022|148
Activation of Wnt Signaling Pathway by Human Papillomavirus E6 and E7 Oncogenes in HPV16-Positive Oropharyngeal Squamous Carcinoma Cells
|Molecular Cancer Research|2010|120